Ingredient or product comparison
Best Peptides for Eye Health: Research Compound Comparison
Before selecting peptides for ocular health research, compare their mechanisms, evidence base, and practical limitations. This table distills what matters. Thymalin Immunomodulation via T-cell regulation in retinal tissue Reduced microglial activation 40–60% i
This source-based comparison does not add ratings or recommend a winner.
- Before selecting peptides for ocular health research, compare their mechanisms, evidence base, and practical limitations. This table distills what matters.
- Thymalin
- Immunomodulation via T-cell regulation in retinal tissue
- Reduced microglial activation 40–60% in retinitis pigmentosa models; slowed photoreceptor apoptosis in inflammatory retinal degeneration
- Low. Stable as lyophilized powder, straightforward subcutaneous reconstitution
- Best suited for conditions where chronic retinal inflammation drives degeneration (uveitis, autoimmune retinopathy). Limited evidence in non-inflammatory models.
- Cerebrolysin
- Neurotrophic factor upregulation (BDNF, NGF) supporting retinal ganglion cell survival
- Increased ganglion cell survival 25–35% post-optic nerve injury; improved visual evoked potentials in glaucoma models
- Moderate. Requires refrigerated storage as liquid formulation, cold chain critical
- Most compelling for optic neuropathies (glaucoma, ischemic optic neuropathy) where ganglion cell death is primary pathology. No effect on photoreceptor-specific degeneration.
- P21
- CNTF pathway activation improving photoreceptor mitochondrial function
- Reduced lipofuscin accumulation in RPE cell cultures; improved photoreceptor survival under oxidative stress in retinal explant models
- Moderate. Lyophilized form stable, but dosing requires precise titration for CNS-active effects
- Strongest theoretical basis for age-related macular degeneration where mitochondrial RPE dysfunction precedes photoreceptor loss. In vivo translation still early-stage.
- Dihexa
- HGF (hepatocyte growth factor) pathway potentiation with neurotrophic effects
- Cognitive enhancement in Alzheimer's models suggests potential for retinal applications, but direct ocular research limited
- High. Extremely potent (nanomolar activity), narrow therapeutic window, significant CNS effects at higher doses
- Experimental for ocular applications. Mechanism suggests benefit for ganglion cells, but lack of retina-specific studies makes this speculative compared to Cerebrolysin.